BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15105892)

  • 1. [Are there new possibilities in immunomorphology?].
    Szekeres G
    Magy Onkol; 2004; 48(1):21-5. PubMed ID: 15105892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical approaches to the diagnosis of undifferentiated malignant tumors.
    Wick MR
    Ann Diagn Pathol; 2008 Feb; 12(1):72-84. PubMed ID: 18164421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical tumor diagnosis--possibilities and limitations].
    Brandtzaeg P
    Tidsskr Nor Laegeforen; 1994 Aug; 114(20):2386-91. PubMed ID: 7527942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of immunocytochemistry in practical diagnosis by the pathologist. Areas of use--methods--cost planning].
    Seifert G; Denk H; Klein PJ; Stein H; Otto HF
    Pathologe; 1984 Jul; 5(4):187-99. PubMed ID: 6435115
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunohistochemistry (I)].
    Serrano Figueras S; Cordón Cardó C; Corominas Torres JM
    Med Clin (Barc); 1985 Mar; 84(9):366-72. PubMed ID: 3887055
    [No Abstract]   [Full Text] [Related]  

  • 6. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma.
    Suster S; Moran CA
    Adv Anat Pathol; 2006 Nov; 13(6):316-29. PubMed ID: 17075297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
    Cuatrecasas M; Catasus L; Palacios J; Prat J
    Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry.
    Kushitani K; Takeshima Y; Amatya VJ; Furonaka O; Sakatani A; Inai K
    Pathol Int; 2008 Feb; 58(2):75-83. PubMed ID: 18199156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemistry: an indispensable technique in routine cytology.
    Skoog L; Tani E
    Cytopathology; 2011 Aug; 22(4):215-29. PubMed ID: 21771092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of claspin as a proliferation marker in human cancer and normal tissues.
    Tsimaratou K; Kletsas D; Kastrinakis NG; Tsantoulis PK; Evangelou K; Sideridou M; Liontos M; Poulias I; Venere M; Salmas M; Kittas C; Halazonetis TD; Gorgoulis VG
    J Pathol; 2007 Feb; 211(3):331-9. PubMed ID: 17152083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.
    McCabe A; Dolled-Filhart M; Camp RL; Rimm DL
    J Natl Cancer Inst; 2005 Dec; 97(24):1808-15. PubMed ID: 16368942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In practice for the pathologist: practical and technical limitations].
    Rochaix P
    Ann Pathol; 2011 Nov; 31(5 Suppl):S43-5. PubMed ID: 22054457
    [No Abstract]   [Full Text] [Related]  

  • 13. Freshly prepared immune complexes with intermittent microwave irradiation result in rapid and high-quality immunostaining.
    Hatta H; Tsuneyama K; Kumada T; Zheng H; Cheng C; Cui Z; Takahashi H; Nomoto K; Murai Y; Takano Y
    Pathol Res Pract; 2006; 202(6):439-45. PubMed ID: 16635554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Back to the drawing board on immunohistochemistry and predictive factors.
    Henson DE
    J Natl Cancer Inst; 2005 Dec; 97(24):1796-7. PubMed ID: 16368935
    [No Abstract]   [Full Text] [Related]  

  • 15. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of GLUT1 expression in adenocarcinoma and adenoma of the ampulla of Vater.
    Kim SJ; Lee HW; Kim DC; Rha SH; Hong SH; Jeong JS
    Pathol Int; 2008 Apr; 58(4):233-8. PubMed ID: 18324916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of biotin-avidin system in targeted magnetic resonance imaging].
    Liu X; Xu YK; Ye J
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1130-2. PubMed ID: 15485783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update.
    Baker PM; Oliva E
    Int J Gynecol Pathol; 2005 Jan; 24(1):39-55. PubMed ID: 15626916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
    Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
    Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.